Related Experiment Video
Updated: Dec 27, 2025

09:34
A Method to Estimate Cadaveric Femur Cortical Strains During Fracture Testing Using Digital Image Correlation
Published on: September 14, 2017
7.7K
Low-dose and sparse sampling MDCT-based femoral bone strength prediction using finite element analysis
Nithin Manohar Rayudu1, D Praveen Anitha1, Kai Mei2
1Engineering Product Development (EPD) Pillar, Singapore University of Technology and Design (SUTD), 8 Somapah Road, Singapore, 487372, Singapore.
Archives of Osteoporosis
|February 24, 2020
Summary
Sparse sampling in multi-detector computed tomography (MDCT) allows up to 50% radiation dose reduction for predicting femoral bone strength using finite element (FE) analysis. This method shows promise for osteoporosis fracture risk assessment with lower radiation exposure.
Area of Science:
- Radiology and Imaging Science
- Biomedical Engineering
- Orthopedic Biomechanics
Background:
- Multi-detector computed tomography (MDCT) is crucial for predicting femoral bone strength using finite element (FE) analysis.
- Reducing radiation dose in MDCT is essential for patient safety, especially in chronic conditions like osteoporosis.
Purpose of the Study:
- To evaluate the impact of dose reduction strategies, specifically sparse sampling and reduced tube current, on the accuracy of MDCT-based femoral bone strength prediction via FE analysis.
- To determine the optimal dose reduction method that maintains the reliability of FE-predicted femoral failure load.
Main Methods:
- MDCT scans of 21 subjects with osteoporosis were analyzed.
- Radiation dose was reduced by 50% and 75% using sparse sampling and virtually reduced tube current.
- Finite element analysis was performed on reconstructed images to calculate femoral failure load.
- Root mean square coefficient of variation (RMSCV) and coefficient of correlation (R² ) were used to assess accuracy against original-dose scans.
Main Results:
- A 50% dose reduction using sparse sampling showed minimal impact on FE-predicted femoral failure load (RMSCV=5.70%, R²=0.96), outperforming reduced tube current (RMSCV=20.78%, R²=0.79).
- Higher dose reductions (75%) using either method led to significant inaccuracies in failure load prediction.
- Sparse sampling demonstrated superior performance in maintaining prediction accuracy at reduced radiation doses.
Conclusions:
- Up to a 50% dose reduction via sparse sampling is feasible for accurate FE-based prediction of femoral failure load.
- Sparse-sampled MDCT offers a potential pathway for fracture risk prediction and treatment monitoring in osteoporosis with reduced radiation exposure.
- This approach could enhance the clinical utility of MDCT in managing osteoporosis patients.

